首页> 美国卫生研究院文献>BMC Cancer >Correction to: Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer

【2h】

Correction to: Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer

机译：更正为：热量限制和运动保护不受蒽环类药物毒性影响（CREATE）研究的原理和设计：一项针对早期乳腺癌的3臂平行组II期随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 BMC Cancer
作者
Amy A. Kirkham; D. Ian Paterson; Carla M. Prado; John R. Mackey; Kerry S. Courneya; Edith Pituskin; Richard B. Thompson;
展开▼
作者单位

展开▼
年(卷),期 2019(19),-1
年度 2019
页码 75
总页数 1
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献

1. Correction to: Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer [J] . Amy A. Kirkham, D. Ian Paterson, Carla M. Prado, BMC Cancer . 2019,第1期

机译：纠正：从蒽环类毒性作用（创造）研究中的热量限制和运动保护的理由和设计：早期乳腺癌中的3臂平行组第II期随机对照试验
2. Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer [J] . Amy A. Kirkham, D. Ian Paterson, Carla M. Prado, BMC Cancer . 2018,第1期

机译：蒽环素毒性作用的热量限制和运动保护的理由和设计研究：早期乳腺癌中的3臂平行组第II期随机对照试验
3. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial [J] . Kinney Anita Y., Howell Rachel, Ruckman Rachel, Contemporary clinical trials . 2018,第期

机译：在种族和地理位置癌症幸存者中促进遗传性乳腺癌和卵巢癌的指南癌症遗传风险评估：三臂随机对照试验的理由和设计
4. Clinical studies of SP1049C, a polymer based anthracycline effective against drug resistant tumors. Results of phase II trial and pivotal phase Ⅲ program in upper gastrointestinal cancer indications [C] . Valery Alakhov Controlled Release Society Annual Meeting and Exposition . 2007

机译：SP1049C的临床研究，一种基于聚合物的蒽环类药物可有效抵抗耐药性肿瘤。上消化道癌适应症的II期试验和关键性III期试验结果
5. Population-based case-control study of the effects of nonsteroidal antiinflammatory drugs on the risk of breast cancer. [D] . Sharpe, Colin Roberton. 2000

机译：非甾体类抗炎药对乳腺癌风险影响的基于人群的病例对照研究。
6. Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer [O] . Amy A. Kirkham, D. Ian Paterson, Carla M. Prado, 2018

机译：不受蒽环类药物毒性影响（CREATE）研究的热量限制和运动保护的原理和设计：早期乳腺癌的3臂平行组II期随机对照试验
7. Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods [O] . Christina M Dieli-Conwright, Joanne E Mortimer, E Todd Schroeder, 2014

机译：评估乳腺癌患者幸存者代谢综合症对综合综合症的影响的随机对照试验：基本原理，设计和方法

Correction to: Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer

著录项

相似文献

相关主题

期刊订阅